Oral cancer is a deadly disease. It is often diagnosed late with considerable spread, resulting in a high mortality rate and treatment-associated morbidity. New devices entering the market have stimulated a renewed interest in oral cancer screening among dental professionals. The British Columbia Oral Cancer Prevention Program (BC OCPP) is actively involved in research related to a variety of emerging technologies, including the intraoral application of devices aimed at improving visualization of oral mucosal abnormalities based on a better understanding of the molecular and pathological alterations associated with premalignancy and cancer.

Autori
Denise M. Laronde, RDH, MSc
Catherine F. Poh, DDS, PhD, Cert Oral Path, FRCD(C)
P. Michele Williams, BSN, DMD, Cert Oral Path, FRCD(C)
T. Greg Hislop, MD
Lewei Zhang, DDS, PhD, Cert Oral Path, FRCD(C)
Calum MacAulay, PhD
Miriam P. Rosin, PhD